We are monitoring the impact of COVID-19 on Influenza Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1621
Share on
Share on

Global Influenza Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product Type (Vaccines & Drugs), Consumer and Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1621
Pages: 170

Global Influenza Market Size (2021 to 2026)

The global influenza market size is expected to reach USD 11.49 billion by 2026 from USD 7.63 billion in 2021, growing at a CAGR of 8.54% during the forecast period.

Influenza is a flu or viral infection which affects the respiratory system. The person affected by influenza may suffer from usual symptoms such as headaches, fever, fatigue, cough, muscle aches, congestion, and running nose. There are four types of influenza viruses: type A, B, C, and D. These viruses travel through the respiratory system and transmit through direct contact or by taking virus-infected air particles. Influenza can be ideally prevented by vaccination. 

MARKET DRIVERS:

increased focus of governments to provide better medical solutions for the people, enhancement of existing vaccines, low risk of side effects associated with influenza vaccines are some of the significant factors that boost the growth of the global influenza market.

The other factors that boost the influenza market's growth are increased funding for research and development activities, the emergence of novel vaccines, and the increased prevalence of medical tourism.

The influenza market is expected to provide lucrative growth opportunities for the key players in the market, owing to the increased account of immunization programs at regular intervals. The availability of various influenza vaccines that have been prequalified by the world health organization and bought by united Nations agencies has provided many opportunities for the growth of the global influenza market. It is expected to continue the trend during the forecast period. Many influenza vaccines for treating the influenza A virus in animals are under the development phase, and trials are supposed to be launched over time. In addition, influenza vaccines are being modified specially for seasons to tackle the virus strains, which alter each season; these factors push the significant market players to develop new vaccines at regular intervals to milk the global influenza market opportunities.  

MARKET RESTRAINTS:

The key factors that challenge the growth of the global influenza market are the time required for the production of the vaccine and the manufacturing costs associated with very high development.  

Impact of COVID-19 on the global influenza market:

The COVID-19 epidemic has had a huge impact on countries worldwide, putting a financial strain on the population. The World Health Organization (WHO) declared the coronavirus epidemic a public health emergency in January 2020. Influenza is a viral infection of the respiratory system that causes fever, body aches, runny nose, cough, congestion, headaches, and exhaustion in those that are infected. Influenza, also known as the flu, is a contagious disease caused by a bacterial infection. It is very infectious and spreads mostly by respiratory droplets. The increased emphasis on research activities to produce a vaccine to contain the widespread impact of the novel coronavirus is boosting global demand for immunization. The pandemic of COVID-19 has caused unprecedented changes in the healthcare sector. In the near term, the industry is expected to benefit from increased demand for seasonal influenza vaccines to ensure improved safety against the deadly pandemic. As a result, improved R&D leading to the production of a new COVID-19 vaccine is expected to boost the sales potential of the market. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Product Type, Consumer, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan) and CSL Limited (Australia)

 

This research report on the global influenza market has been segmented and sub-segmented based on product type, consumer, and region.

Influenza Market - By Product Type:

  • Vaccines
  • Drugs

Based on product type, the Vaccines segment holds a significant market share during the forecast period. The market is expected to grow due to the rising demand for seasonal influenza vaccination to guarantee greater protection against the deadly pandemic. In addition, global healthcare organizations such as the Centers for Disease Control and Prevention (CDC) have suggested baloxavir marboxil (Xofluza) vaccines to treat the symptoms in patients due to their significant health consequences.

Influenza Market - By Consumer:

  • Children
  • Adults

Based on the consumers, the children segment had a larger market size in 2020. This dominance is due to greater vaccine doses given to neonates, babies, and children to protect them against influenza illness from an early age. The high prevalence of influenza infection and its frequency among young children has prompted a variety of methods. In addition, according to the CDC, flu-related hospitalizations among children have boosted the need for childhood vaccinations in the newborn age group.

Adult vaccination is now required to reduce the number of hospitalizations and fatalities caused by influenza. Due to the government's increased vaccination efforts and high vaccine dosage procurement by GAVI, PAHO, and UNICEF, adult vaccines have a substantial market share in this market.

Influenza Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America is leading the global influenza vaccine market by contributing the largest share of revenues and is expected to continue the trend owing to the factors such as the increased focus of governments on immunization programs, improvements in vaccine administration, increased incidence of influenza in the region, and the influx of new vaccines. North America is expected to dominate the global influenza market during the forecast period. This dominance can be due to the fact that certain companies are concentrating more on manufacturing innovative influenza vaccines for therapeutic purposes in countries such as the United States. Factors such as rising influenza prevalence and the number of influenza screening tests conducted in this area propel the North American market forward throughout the forecast period. The rapid development of efficient influenza vaccines and the broad use of technologically advanced vaccine production processes are expected to drive regional market growth. In addition, growing influenza incidence and high vaccine sales are expected to drive market growth in North America.

Europe ranked second in the market and is projected to see substantial growth due to the expansion of vaccine coverage for high-risk populations, resulting in greater immunization rates among the European population. Additionally, product launches in the area are expected to boost adoption rates.

Because of improvements in healthcare facilities, increased disposable money, and rapid economic growth, LAMEA is anticipated to become a profitable market for influenza vaccinations.

LAMEA is another major contributor to the global market and is expected to grow rapidly during the forecast period due to factors like an increase in disposable income, advancements in healthcare facilities, and escalated growth of economies.

KEY MARKET PLAYERS:

Some of the promising companies leading the global influenza market profiled in this report are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan) and CSL Limited (Australia).

RECENT MARKET DEVELOPMENTS:

  • ResVax vaccine, a vaccine developed by Novavax Company for RSV diseases, has completed phase 3 of the trial process, and the outcomes were announced at the IDSOG meeting in August 2019.
  • Emergent BioSolutions Company has developed a vaccine called NuThrax anthrax vaccine, for which the company has enrolled patients to begin the phase 3 trial of clinical study in 2018. The vaccine is a combination of anthrax and BioThrax vaccine developed by the Emergent, which improves the body's immune response.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Introduction           

                                5.1.2 Vaccines   

                                5.1.3 Drugs         

                                5.1.4  Y-o-Y Growth Analysis, By Product              

                                5.1.5  Market Attractiveness Analysis, By Product            

                                5.1.6  Market Share Analysis, By Product              

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Safety Biomarkers

                                5.2.3 Efficacy Biomarkers             

                                5.2.4 Validation Biomarkers        

                                5.2.5  Y-o-Y Growth Analysis, By Type    

                                5.2.6  Market Attractiveness Analysis, By Type  

                                5.2.7  Market Share Analysis, By Type    

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Diagnostics Development 

                                5.3.3 Drug Discovery and Development

                                5.3.4 Personalised Medicine      

                                5.3.5 Disease Risk Assessment  

                                5.3.6 Other Applications               

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 Disease Indications                 

                                5.4.1 Introduction           

                                5.4.2 Cancer      

                                5.4.3 CardiovascularDisorders    

                                5.4.4 Neurological Disorders       

                                5.4.5 Immunological Disorders  

                                5.4.6 Other Diseases      

                                5.4.7  Y-o-Y Growth Analysis, By Disease Indications        

                                5.4.8  Market Attractiveness Analysis, By Disease Indications 

                                5.4.9  Market Share Analysis, By Disease Indications 

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Application

                                                6.1.3.5 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Type

                                                6.1.4.4 By Application

                                                6.1.4.5 By Indication

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Type

                                                6.1.5.4 By Application

                                                6.1.5.5 By Indication

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Sanofi-Pasteur                          

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 AstraZeneca                               

                8.3 F. Hoffmann-La Roche                           

                8.4 Novartis                       

                8.5 GlaxoSmithKline                       

                8.6 Pfizer Inc.                    

                8.7 Merck & Co.                               

                8.8 Abbott Laboratories                               

                8.9 Mitsubishi Tanabe Pharma Corporation                         

                8.10 CSL Limited                               

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Influenza Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  3. Global Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  6. Global Children Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Adults Market, By Region, From 2021 to 2026 (USD Billion)
  8. North America Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  9. North America Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  10. North America Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  11. North America Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  12. North America Children Market, By Region, From 2021 to 2026 (USD Billion)
  13. North America Adults Market, By Region, From 2021 to 2026 (USD Billion)
  14. United States Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  15. United States Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  16. Canada Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  17. Canada Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  18. Europe Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  19. Europe Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  20. Europe Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  21. Europe Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  22. Europe Children Market, By Region, From 2021 to 2026 (USD Billion)
  23. Europe Adults Market, By Region, From 2021 to 2026 (USD Billion)
  24. U.K. Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  25. U.K. Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  26. Germany Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  27. Germany Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  28. France Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  29. France Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  30. Italy Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  31. Italy Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  32. Spain Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  33. Spain Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  34. Asia-Pacific Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  35. Asia-Pacific Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  36. Asia-Pacific Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  37. Asia-Pacific Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  38. Asia-Pacific Children Market, By Region, From 2021 to 2026 (USD Billion)
  39. Asia-Pacific Adults Market, By Region, From 2021 to 2026 (USD Billion)
  40. Japan Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  41. Japan Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  42. China Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  43. China Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  44. India Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  45. India Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  46. Australia Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  47. Australia Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  48. South Korea Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  49. South Korea Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  50. Latin America Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  51. Latin America Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  52. Latin America Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  53. Latin America Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  54. Latin America Children Market, By Region, From 2021 to 2026 (USD Billion)
  55. Latin America Adults Market, By Region, From 2021 to 2026 (USD Billion)
  56. Brazil Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  57. Brazil Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  58. Argentina Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  59. Argentina Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  60. Mexico Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  61. Mexico Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  62. Rest of Latin America Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  63. Rest of Latin America Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  64. Middle East & Africa Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  65. Middle East & Africa Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  66. Middle East & Africa Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  67. Middle East & Africa Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  68. Middle East & Africa Children Market, By Region, From 2021 to 2026 (USD Billion)
  69. Middle East & Africa Adults Market, By Region, From 2021 to 2026 (USD Billion)
  70. Middle East Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  71. Middle East Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)
  72. Africa Influenza Market, By Product Type, From 2021 to 2026 (USD Billion)
  73. Africa Influenza Market, By Consumer, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample